Rami Manochakian, MD, FASCO, of the Mayo Clinic, Florida, who served as the lung cancer panelist during Advancements in Oncology, discusses what oncologists need to know about advances in lung cancer treatment and the latest data. Dr. Manochakian joined The Oncology Brothers, Rahul Gosain, MD, MBA, and Rohit Gosain, MD, during their Advancements in Oncology event held on June 1 to discuss major updates in lung cancer treatment from the 2024 American Society of Clinical Oncology Annual Meeting. ...
Advancements in Oncology: Today's Data for Tomorrow's Practice
An Oncology Brothers Event
Review exclusive coverage of Advancement in Oncology: Today’s Data for Tomorrow’s Practice, held at theWit Chicago on June 1, 2024. This first event co-hosted by The Oncology Brothers and Mashup Media features breakthrough data on breast, gastrointestinal, and lung cancers and insights from an esteemed panel of experts, aiming to bridge the gap between research and practice for community oncologists.
Advertisement
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Manochakian discusses the most pressing unanswered questions in lung cancer and how they could be addressed.
Dr. Manochakian reflects on progress in lung cancer treatment and why it's critical to bring it to the community setting.
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Dr. Eng opines on how the ESOPEC study will alter the treatment paradigm for patients with esophageal/GEJ adenocarcinoma.
Dr. Eng comments on how she approaches treatment considerations and management for her younger patients with colon cancer.
Dr. Eng explains how she makes sense of the stage 4 third-line therapy options to administer to her colon cancer patients.
Dr. Eng shares what the COMMIT study suggest about colon cancer and this study's applicability outside of liver metastasis.
Dr. Manochakian shared his insights during the Oncology Brothers Advancements in Oncology event.
Dr. Eng provides her thoughts on ctDNA upfront, sequential, and combined with NGS testing for patients with colon cancer.
Dr. Rami Manochakian and The Oncology Brothers discusses treatment for SCLC, which is evolving at a rapid pace.
Dr. Manochakian discusses new data and why next-generation sequencing is a critical step when treating NSCLC.
Dr. Margaret Gatti-Mays, who specializes in breast cancer, delivers key insights on many breast cancer-related topics.
Dr. Ugurlu said the event was an inspiring experience that helped him navigate the latest data in oncology.
The Oncology Brothers and Dr. Manochakian discussed the rapid changes in the perioperative treatment landscape for NSCLC.
Dr. Margaret Gatti-Mays talks with The Oncology Brothers about the right treatments for endocrine-resistant breast cancer.
Dr. Margaret Gatti-Mays details the treatment options for BC patients in the hormone receptor-positive metastatic setting.
The trio pondered the evolving landscape of upper GI cancer treatments, particularly in localized and advanced stages.
The trio delved into the nuances of dosing strategies for TAS-102 and fruquintinib for colorectal cancer, offering insights.
The trio highlighted the evolution of genetic mutations in colon cancer, pointing to recent studies on NGS.
Dr. Eng first shared her expertise on the current approaches to treating colon cancer, focusing on the use of ctDNA.
Dr. Halmos discusses how the Advancements in Oncology event helped unpack the new data for community oncologists.
The Oncology Brothers spoke with Dr. Margaret Gatti-Mays, who provided invaluable insights on hormone receptor-positive BC.
Dr. Singhi discusses the event held by The Oncology Brothers during the American Society of Clinical Oncology Annual Meeting.
Rami Manochakian, MD, FASCO, shared his insights on key lung cancer updates during the event.
Advancements in Oncology, an innovative, panel-based event focused on 4 key areas of cancer, is a can't-miss event.
Advertisement
